A complete application consists of:
All documents must be in English or include an official English translation.
If you have questions, send an email to FDArpp@orau.org. Please include the reference code for this opportunity in your email.
A research opportunity is available at the Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality/Office of Biotechnology Products, Division of Research and Review 1.
The fellow would join a research team working to elucidate the specific contributions of molecular changes observed in human squamous cancers of the head and neck to cancer pathogenesis. Studies will utilize a combination of molecular, biochemical and cell-based approaches. Our research is focused on the role of p53/p63/p73 family gene products (with an emphasis on DNp63a) and their interactions with the RAS and NFkB pathways.
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for 12 months, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, MD area. Participants do not become employees of FDA or the program administrator, and there are no fringe benefits paid.
Applicants must have received a Bachelors or Master’s degree in Biological Sciences, or related disciplines appropriate to the position, from a US-accredited institution within five (5) years of the desired starting date. Hands on experience in biochemistry, molecular biology, and primary cell culture are desired. Note: All applicants must be able to pass a Tier One security screen (non-sensitive), with a residency requirement of three of the past five years in the United States.